CEACAM5 and neoplasm: The possibilities of such analysis in oncology have been enhanced by the discovery of tumor biomarkers such as alpha-fetoprotein, CA125, prostate-specific antigen, cytokeratin 19 fragment and carcinoembryonic antigen (CEA) to name a few [1,2].